Bristol Myers Squibb (BMY) Receivables Refunds (2009 - 2013)

Bristol Myers Squibb (BMY) has 5 years of Receivables Refunds data on file, last reported at $336.0 million in Q1 2013.

• Receivables Refunds for Q1 2013 came in at $336.0 million, up 37.7% year-over-year; the trailing twelve-month figure through Mar 2013 was $336.0 million (up 37.7% YoY), and the FY2012 annual result was $319.0 million, up 24.61% from the prior year.
• Receivables Refunds climbed to $336.0 million in Q1 2013 per BMY's latest filing, from $319.0 million in the prior quarter.
• Over five years, Receivables Refunds peaked at $426.0 million in Q2 2011 and troughed at $103.0 million in Q4 2009.
• A 5-year average of $247.6 million and a median of $244.0 million in 2012 frame the typical range for Receivables Refunds.
• The sharpest annual moves came in 2010 and 2012: Receivables Refunds jumped 116.5% in 2010, then tumbled 65.73% in 2012.
• A 5-year view of Receivables Refunds shows it stood at $103.0 million in 2009, then jumped by 116.5% to $223.0 million in 2010, then increased by 14.8% to $256.0 million in 2011, then advanced by 24.61% to $319.0 million in 2012, then rose by 5.33% to $336.0 million in 2013.
• Business Quant data shows BMY's Receivables Refunds at $336.0 million in Q1 2013, $319.0 million in Q4 2012, and $202.0 million in Q3 2012.